NDC 59417-105

Vyvanse

Lisdexamfetamine Dimesylate

Vyvanse is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is Lisdexamfetamine Dimesylate.

Product ID59417-105_270763e9-f847-407b-ba8c-3e97d5649645
NDC59417-105
Product TypeHuman Prescription Drug
Proprietary NameVyvanse
Generic NameLisdexamfetamine Dimesylate
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2007-02-23
Marketing CategoryNDA / NDA
Application NumberNDA021977
Labeler NameTakeda Pharmaceuticals America, Inc.
Substance NameLISDEXAMFETAMINE DIMESYLATE
Active Ingredient Strength50 mg/1
Pharm ClassesCentral Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE]
DEA ScheduleCII
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 59417-105-10

100 CAPSULE in 1 BOTTLE (59417-105-10)
Marketing Start Date2007-02-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 59417-105-10 [59417010510]

Vyvanse CAPSULE
Marketing CategoryNDA
Application NumberNDA021977
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-02-23

Drug Details

Active Ingredients

IngredientStrength
LISDEXAMFETAMINE DIMESYLATE50 mg/1

OpenFDA Data

SPL SET ID:704e4378-ca83-445c-8b45-3cfa51c1ecad
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1871456
  • 1871459
  • 854842
  • 854840
  • 854846
  • 854844
  • 854848
  • 1871464
  • 1871465
  • 1871466
  • 1871467
  • 1871460
  • 1871461
  • 1871462
  • 1871463
  • 1871468
  • 1871469
  • 1593858
  • 854850
  • 854852
  • 1593856
  • 854836
  • 854834
  • 854832
  • 854830
  • 854838
  • Pharmacological Class

    • Central Nervous System Stimulant [EPC]
    • Central Nervous System Stimulation [PE]

    Medicade Reported Pricing

    59417010510 VYVANSE 50 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Vyvanse" or generic name "Lisdexamfetamine Dimesylate"

    NDCBrand NameGeneric Name
    59417-101Vyvanselisdexamfetamine dimesylate
    59417-102Vyvanselisdexamfetamine dimesylate
    59417-103Vyvanselisdexamfetamine dimesylate
    59417-104Vyvanselisdexamfetamine dimesylate
    59417-105Vyvanselisdexamfetamine dimesylate
    59417-106Vyvanselisdexamfetamine dimesylate
    59417-107Vyvanselisdexamfetamine dimesylate
    59417-115VyvanseLISDEXAMFETAMINE DIMESYLATE
    59417-116VyvanseLISDEXAMFETAMINE DIMESYLATE
    59417-119VyvanseVyvanse
    59417-120VyvanseVyvanse
    59417-118VyvanseVyvanse
    59417-117VyvanseVyvanse

    Trademark Results [Vyvanse]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    VYVANSE
    VYVANSE
    77146381 3595432 Live/Registered
    Shire LLC
    2007-04-02
    VYVANSE
    VYVANSE
    77146317 3793508 Live/Registered
    Shire LLC
    2007-04-02
    VYVANSE
    VYVANSE
    77037206 3468580 Live/Registered
    Shire LLC
    2006-11-06

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.